Do you Treat PTSD? If So, Read This Information


Long-time TFT practitioner, Terri Perry, share the following information.  She said it was originally posted on by Susan V. Ferguson. \

Terri saw the post and thought immediately of TFT people being asked to treat soldiers who may be affected by the drug rather than full-blown PTSD. She also felt it might be worth checking it as a toxin. She said that particular website is very informative for all current events too.

Susan Ferguson says:

July 31, 2021 at 3:12 pm

Veteran Exposes Dangerous Drug Forced on Military
RAIR Foundation /July 31, 2021

Mefloquine Versus Post Traumatic Stress Disorder (PTSD)
Sold under the brand name, Lariam, mefloquine was intended to treat and be a prophylaxis for Malaria, although it was given to soldiers who were not stationed in areas known to be Malaria-infected, according to Beardwood. The drug is “known to cause serious and potentially lasting neuropsychiatric adverse reactions,” according to a 2017 study posted at Pharmacology Research & Perspectives.

Despite the drug not being approved, Health Canada took no steps to ensure the defense department was following “strict protocols on how to individually prescribe the drug, to monitor closely the side effects and to report back,” as reported in the Edmonton Journal in 2016.

Are “neuropsychiatric adverse reactions” from mefloquine ever mistaken for Post Traumatic Stress Disorder (PTSD)? A 2019 article posted at the American Legion shows that the drug was given to American soldiers as well, and could have contributed to a “spate of murders at Fort Bragg in 2002”.

Further, the drug has been implicated in a horrific slaughter of 16 Afghan civilians by former sniper Robert Bales. Tragically, Bales’ attorneys never made the connection and this crucial fact was not addressed during his trial.

It is speculated that mefloquine played a role in the beating death of a Somali teenager during Canada’s engagement in Somalia known as “The Somalia Affair”.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *